Requip xl and Nasonex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Requip xl (ropinirole hydrochloride) and Nasonex (mometasone furoate monohydrate). Common drug interactions include nausea among females and urinary tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Requip xl and Nasonex. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Requip xl?

Requip xl has active ingredients of ropinirole hydrochloride. It is often used in parkinson's disease. eHealthMe is studying from 1,297 Requip xl users. Check the latest studies of Requip xl.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

On Jul, 16, 2026

14 people who take Requip xl and Nasonex together, and have interactions are studied.

Requip xl and Nasonex drug interactions.

What are the common drug interactions of Requip Xl and Nasonex, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Abdominal pain
Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Dizziness postural
Dry mouth
Gastric disorder (disease of stomach)
Surgery
Weight decreased

male:

Urinary tract infection
Drug ineffective
Aphasia (damage to the parts of the brain that control language)
Arthralgia (joint pain)
Aspartate aminotransferase increased
Asthenia (weakness)
Back pain
Blood amylase increased
Blood urea decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the common drug interactions of Requip Xl and Nasonex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Dizziness postural
Nausea (feeling of having an urge to vomit)
Weight decreased

60+:

Urinary tract infection
Abdominal pain
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Fibrin degradation products increased
Fluid retention (an abnormal accumulation of fluid in the blood)
Granulocytosis (the presence in peripheral blood of an increased number of granulocytes)
Hypokinesia (decreased bodily movement)
Ill-defined disorder
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 21.43%
Psychotic Disorder: 3 people, 21.43%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 14.29%
Enlarged Prostate: 2 people, 14.29%
Asthma: 2 people, 14.29%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 14.29%
Constipation: 2 people, 14.29%
Depression: 2 people, 14.29%
Neuropathy Peripheral (surface nerve damage): 2 people, 14.29%
Seasonal Allergy (allergic condition due to certain season): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Requip xl and Nasonex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously